Maximillian J. Woodall

St George's University Of London
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Polymerase-inhibitor drug synergy and mutational signatures in different epithelial cell models of RSVA and hPIV3 infection.

Polymerase-inhibitor drug synergy and mutational signatures in different epithelial cell models of RSVA and hPIV3 infection.

Journal: npj antimicrobials and resistance

Published: January 08, 2026

Polymerase mutations underlie early adaptation of H5N1 influenza virus to dairy cattle and other mammals.

Polymerase mutations underlie early adaptation of H5N1 influenza virus to dairy cattle and other mammals.

Journal: Nature communications

Published: November 13, 2025

Neutrophil myeloperoxidase as a functional biomarker for RSV severity: implications for in vitro therapeutic screening.

Neutrophil myeloperoxidase as a functional biomarker for RSV severity: implications for in vitro therapeutic screening.

Journal: Nature communications

Published: October 13, 2025

Efficient in vitro assay for evaluating drug efficacy and synergy against emerging SARS-CoV-2 strains.

Efficient in vitro assay for evaluating drug efficacy and synergy against emerging SARS-CoV-2 strains.

Journal: Antimicrobial agents and chemotherapy

Published: December 17, 2024

Distinctive T-cell receptor repertoire in paediatric inflammatory multisystem syndrome temporally associated with coronavirus disease 2019/multisystem inflammatory syndrome in children patients: possible thymus involvement.

Distinctive T-cell receptor repertoire in paediatric inflammatory multisystem syndrome temporally associated with coronavirus disease 2019/multisystem inflammatory syndrome in children patients: possible thymus involvement.

Journal: Clinical and experimental immunology

Published: November 27, 2024

Author Correction: Human SARS-CoV-2 challenge uncovers local and systemic response dynamics.

Author Correction: Human SARS-CoV-2 challenge uncovers local and systemic response dynamics.

Journal: Nature

Published: August 01, 2024

Author Correction: Age-specific nasal epithelial responses to SARS-CoV-2 infection.

Author Correction: Age-specific nasal epithelial responses to SARS-CoV-2 infection.

Journal: Nature microbiology

Published: June 18, 2024

A one-step method for generating antimicrobial nanofibre meshes via coaxial electrospinning.

A one-step method for generating antimicrobial nanofibre meshes via coaxial electrospinning.

Journal: Materials advances

Published: February 08, 2024

Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients.

Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients.

Journal: Nature communications

Published: August 04, 2023

Salivary IgA and vimentin differentiate in vitro SARS-CoV-2 infection: A study of 290 convalescent COVID-19 patients.

Salivary IgA and vimentin differentiate in vitro SARS-CoV-2 infection: A study of 290 convalescent COVID-19 patients.

Journal: Mucosal immunology

Published: June 26, 2023

Age-specific nasal epithelial responses to SARS-CoV-2 infection.

Age-specific nasal epithelial responses to SARS-CoV-2 infection.

Journal: Nature microbiology

Published: March 24, 2023

Human SARS-CoV-2 challenge uncovers local and systemic response dynamics.

Human SARS-CoV-2 challenge uncovers local and systemic response dynamics.

Journal: Nature

Published: February 24, 2023

Showing 1-12 of 20

Last Updated: 09/26/2026